col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Open Exploration Publishing

63 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Exploration of Immunology 2024―Feb―29 Myelitis associated with COVID-19: clinical, radiological, and laboratory characteristics Aleksandra Kozlova, Alina Dzharullaeva, Amir Tukhvatulin, Inessa Zakroyshchikova, Taras Simaniv, Lola Askarova, et al. (+5)
2 [GO] Exploration of Digital Health Technologies 2024―Feb―28 System for classifying antibody concentration against severe acute respiratory syndrome coronavirus 2 S1 spike antigen with automatic quick response generation for integration with health passports Apostolos Apostolakis, Dimitris Barmpakos, Sofia Mavrikou, George Marios Papaionannou, Vasileios Tsekouras, Kyriaki Hatziagapiou, et al. (+7)
3 [GO] Exploration of Immunology 2024―Jan―31 Paradigm of immune dysregulation in coronavirus disease-2019 infection Om Saswat Sahoo, Karthikeyan Pethusamy, Arnab Nayek, Rashmi Minocha, Ruby Dhar, Subhradip Karmakar
4 [GO] Exploration of Targeted Anti-tumor Therapy 2023―Dec―27 Telehealth in breast cancer following the coronavirus disease 2019 pandemic Jean Zeghondy, Elie Rassy, Pietro Lapidari, Roland Eid, Barbara Pistilli
5 [GO] Exploration of Medicine 2023―Nov―01 Figuring the characteristics of the Delta variant SARS-CoV-2 gene mutations in an Indonesian hospital: a descriptive study Phey Liana, Muhammad Agung Maulana, Eny Rahmawati, Rouly Pola Pasaribu, Kemas Yakub Rahadiyanto, Nelda Aprilia Salim, Tungki Pratama Umar
6 [GO] Exploration of Targeted Anti-tumor Therapy 2023―Oct―31 Coronavirus disease 2019 and lung cancer: where are we? Abrahams Ocanto, Xabier Mielgo-Rubio, Javier Luna Tirado, Nuria Linares Mesa, Marta López Valcárcel, Sara Pedraza, et al. (+4)
7 [GO] Exploration of Targeted Anti-tumor Therapy 2023―Oct―31 Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology Veronica Agostinelli, Zelmira Ballatore, Giulia Ricci, Alessandra Lucarelli, Michela Burattini, Lorenzo Mariotti, et al. (+3)
8 [GO] Exploration of Cardiology 2023―Oct―30 Cardiovascular imaging in COVID-19: insights into features and complications Iwona Duraj, Małgorzata Kilarska, Agnieszka Pawlos, Karina Wierzbowska-Drabik
9 [GO] Exploration of Targeted Anti-tumor Therapy 2023―Oct―26 A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors Babak Sokouti
10 [GO] Exploration of Targeted Anti-tumor Therapy 2023―Oct―26 Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review Afrooz Mazidimoradi, Samane Sabet Birjandi, Hamid Salehiniya
11 [GO] Exploration of Drug Science 2023―Oct―25 Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies Atri Das, Swarnali Khan, Syamal Roy, Shantanabha Das
12 [GO] Exploration of Immunology 2023―Oct―16 Loss of regulation of T helper 17 cells: a definitive factor for critical cases of coronavirus disease 2019 Miguel Angel Pardiño-Vega, Norma Estela Herrera-González
13 [GO] Exploration of Immunology 2023―Oct―11 Effect of coronavirus disease 2019 on the vaccine development paradigm Sezer Okay
14 [GO] Exploration of Targeted Anti-tumor Therapy 2023―Sep―07 A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic Zelmira Ballatore, Amalia Goudas, Francesco Bozzi, Alessandra Lucarelli, Michela Burattini, Giulia Ricci, et al. (+2)
15 [GO] Exploration of Medicine 2023―Aug―31 Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications Hannah Thurgur, Anne Katrin Schlag, Elizabeth Iveson, Adele Hosseini, Michael Lynskey, David J. Nutt
16 [GO] Exploration of Drug Science 2023―Aug―29 Natural compounds from medicinal plants against COVID-19 Anton Kolodnitsky, Nikita Ionov, Irina Gravel, Vladimir Poroikov
17 [GO] Exploration of Immunology 2023―Aug―24 Trained-immunity and cross-reactivity for protection: insights from the coronavirus disease 2019 and monkeypox emergencies for vaccine development Amanda Izeli Portilho, Elizabeth De Gaspari
18 [GO] Exploration of Immunology 2023―Aug―04 COVID-19 induced ARDS: immunopathology and therapeutics Sneha Das, Tamanna Sharma, Asha Bhardwaj, Rupesh K. Srivastava
19 [GO] Exploration of Medicine 2023―Jun―28 The impact of COVID-19 pandemic on diagnosis and management of gastrointestinal cancers Byung Soo Yoo, Ankit Patel, Kevin V. Houston, Alejandra Vargas, Ana Rosa Vilela Sangay, Steve M. D’Souza, David A. Johnson
20 [GO] Exploration of Medicine 2023―Jun―28 Association between coronavirus 2019 disease and pseudoneurological complaints: analysis of case-control data Mohammad Ali, Atia Sharmin Bonna, Tajnuva Mehjabin
21 [GO] Exploration of Asthma & Allergy 2023―Apr―27 Allergists/immunologists facing the coronavirus disease 2019 pandemic: the experience of managing a low-care setting Laura Franceschini, Giancarlo Landini, Alessandro Farsi
22 [GO] Exploration of Medicine 2023―Apr―26 Gastrointestinal microbiome and coronavirus disease: evidence of a bidirectional association Kevin V. Houston, Ankit Patel, Michael Saadeh, Alejandra Vargas, Ana Rosa Vilela Sangay
23 [GO] Exploration of Medicine 2023―Apr―26 Mechanistic approaching study in COVID-19 patients treated with high doses of vitamin D Mauro G. Silva, Felipe Inserra, Javier Mariani, Laura Antonietti, Myriam Nuñez, Carlos Tajer, et al. (+10)
24 [GO] Exploration of Medicine 2023―Apr―26 Immunomodulation strategies against COVID-19 evidence: key nutrients and dietary approaches Lindsey B. Cundra, Manasa Vallabhaneni, Michael Saadeh, Kevin V. Houston, Byung Soo Yoo, Steve D’Souza, David A. Johnsonv
25 [GO] Exploration of Immunology 2023―Mar―01 SARS-CoV-2 infection activates the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes pathway in the lung: a review Gislei F. Aragão, Sthefane G. Feitosa, Herlice Do Nascimento Veras, Cícero Gilmário A. P. de Lima Filho, Karinne da S. Assunção, Luana M. Arrais, Sara Lívia M. Teixeira
26 [GO] Exploration of Medicine 2023―Mar―01 m6 RNA methylation: an emerging common target in the immune response to cancer and severe acute respiratory syndrome-coronavirus-2 infection Hiromichi Sato, Tomoaki Hara, Chihiro Otsuka, Yasuko Arao, Yoshiko Tsuji, Yumiko Hamano, et al. (+5)
27 [GO] Exploration of Immunology 2023―Feb―27 Innate immune cell and severe acute respiratory syndrome coronavirus 2 interaction Naima G. Cortes-Perez
28 [GO] Exploration of Medicine 2023―Feb―27 Molecular docking analysis of peptide-based antiviral agents against SARS-CoV-2 main protease: an approach towards drug repurposing Abhishek Chaurasiya, Abhimannu Shome, Pooja A. Chawla
29 [GO] Exploration of Medicine 2022―Dec―30 Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease Saksena Nitin, Bonam Srinivasa R., Miranda-Saksena Monica, Cardoso Thyago H.
30 [GO] Exploration of Medicine 2022―Dec―29 Right atrial thrombus, junctional tachycardia, and critical lower limb ischemia: three rare complications of severe acute respiratory syndrome coronavirus 2 infection Said Makani, Aziza Laarje, Meryem Mabrouk, Younes Zaid, Malak Chahid, Zaynab Hifdi, et al. (+4)
31 [GO] Exploration of Immunology 2022―Sep―21 Immune responses to SARS-CoV-2 infection and COVID-19 vaccines Basista Rabina Sharma, P. Veeranna Ravindra
32 [GO] Exploration of Immunology 2022―Aug―26 Immune network operations in COVID-19 Javier Burgos-Salcedo
33 [GO] Exploration of Immunology 2022―Aug―11 Small molecules targeting endolysosomal acidification and signaling in sepsis and severe SARS-CoV-2 infection/COVID-19 Markus Blaess, Oliver Sommerfeld, René Csuk, Hans-Peter Deigner
34 [GO] Exploration of Targeted Anti-tumor Therapy 2022―Jul―29 Consequences of the impact of COVID-19 pandemic on breast cancer at a single Italian institution Daniele Ugo Tari, Rosalinda Santonastaso, Fabio Pinto
35 [GO] Exploration of Immunology 2022―Jul―18 In COVID-19, antigen size lower or larger than 70 kDa modulates the sepsis and memory B cells Francisco Javier Martín Oncina
36 [GO] Exploration of Targeted Anti-tumor Therapy 2022―Jun―10 Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows Mariangela Torniai, Veronica Agostinelli, Luca Cantini, Carolina Liguori, Francesca Morgese, Silvia Rinaldi, et al. (+2)
37 [GO] Exploration of Medicine 2022―Jun―09 Early taurine administration as a means for halting the cytokine storm progression in COVID-19 patients Alberto Rubio-Casillas, Ramesh C. Gupta, Elrashdy M. Redwa, Vladimir N. Uversky, Raied Badierah
38 [GO] Exploration of Immunology 2022―May―17 SARS-CoV-2: overview of immune response, insights into vaccine platforms and their challenges Balram Ji Omar, Arpana Singh, Vanya Singh, Ashish Kothari, Manju O. Pai
39 [GO] Exploration of Immunology 2022―Mar―16 High avidity of vaccine-induced immunoglobulin G against SARS-CoV-2: potential relevance for protective humoral immunity Georg Bauer
40 [GO] Exploration of Neuroprotective Therapy 2022―Mar―02 Subarachnoid hemorrhage: management considerations for COVID-19 Eric J. Panther, Brandon Lucke-Wold
41 [GO] Exploration of Immunology 2022―Feb―11 Immune titers of protection against severe acute respiratory syndrome coronavirus 2: are we there yet? Yoanna Slabakova, Dilyana Gerenska, Nedelcho Ivanov, Tsvetelina Velikova
42 [GO] Exploration of Medicine 2022―Jan―25 Fertility and COVID-19 vaccination Iosif M. Gershteyn
43 [GO] Exploration of Medicine 2022―Jan―18 Preclinical toxicity test results of a new antiviral-immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data) Gürer G. Budak, Seçil Özkan, Mehmet Budak, Tamay Şeker, Bahar Meryemoglu, Şükran Selin Miran, et al. (+2)
44 [GO] Exploration of Medicine 2021―Dec―31 Preclinical toxicity test results of a new antiviral-immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data) Gürer G. Budak, Seçil Özkan, Mehmet Budak, Tamay Şeker, Bahar Meryemoglu, Şükran Selin Miran, et al. (+2)
45 [GO] Exploration of Immunology 2021―Dec―31 State-of-the-art preclinical evaluation of COVID-19 vaccine candidates Devlina Ghosh, Bingxin Bai, Qun Ji, Soumya Palliyil, Guang Yang, Alok Kumar, Abhishek Saxena
46 [GO] Exploration of Immunology 2021―Dec―31 New variants of SARS-CoV-2, vaccine immune response and the Brazilian reality Marileia Andrade, Luiza Gomes, Vitória Mendes, Hellen Rosa
47 [GO] Exploration of Immunology 2021―Dec―14 Activation of mucosal immunity and novel prophylactic and therapeutic strategy in combating COVID-19 Swapan K. Chatterjee, Snigdha Saha, Maria Nilda M. Munoz
48 [GO] Exploration of Immunology 2021―Dec―13 COVID-19 vaccine and immune response Sevilay Hintistan, Hatice Demirağ
49 [GO] Exploration of Immunology 2021―Dec―10 Vaccine-induced immune responses against SARS-CoV-2 infections Mandeep Garg, Muniraju Maralakunte, Yashwant Kumar, Harish Bhujade, Inder Paul Sehgal, Vikas Suri, Suruchi Garg
50 [GO] Exploration of Targeted Anti-tumor Therapy 2021―Nov―01 Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center Maristella Bungaro, Valentina Bertaglia, Marco Audisio, Elena Parlagreco, Chiara Pisano, Valeria Cetoretta, et al. (+9)
51 [GO] Exploration of Immunology 2021―Nov―01 Viral vector-based vaccines against SARS-CoV-2 Kenneth Lundstrom
52 [GO] Exploration of Medicine 2021―Oct―09 A review of aortic thrombosis in COVID-19 infection Korin Karabulut, Ahmet Kapici, Ana Andronikashvili, James Morgan
53 [GO] Exploration of Immunology 2021―Sep―30 Immune responses induced by different vaccine platforms against coronavirus disease-19 Eknath D. Ahire, Sanjay J Kshirsagar
54 [GO] Exploration of Immunology 2021―Sep―01 Severe acute respiratory syndrome coronavirus 2 targeted antibodies cocktail and B cell receptor interplay: interventions to trigger vaccine development Kabeer Haneef, Rabia Saleem, Muhammad Saleem Iqbal Khan, Olawale Samuel Adeyinka, Sadeeq Banday, Muhammad Umer Asghar, et al. (+2)
55 [GO] Exploration of Immunology 2021―Sep―01 The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal Eduardo Tosta
56 [GO] Exploration of Immunology 2021―Sep―01 Conserved envelope protein of nCoV2 as the possible target to design polytope vaccine Krupanidhi Sreerama
57 [GO] Exploration of Medicine 2021―Aug―30 High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases Maria Giulia Cornacchia, Moris Sangineto, Rosanna Villani, Francesco Cavallone, Giuseppe Di Gioia, Paola Cicciomessere, Gaetano Serviddio
58 [GO] Exploration of Immunology 2021―Jul―01 Immunopathogenesis of severe acute respiratory syndrome coronavirus-2: evolving knowledge and its current status Nitin Saksena, Srinivasa Reddy Bonam, Monica Miranda-Saksena
59 [GO] Exploration of Medicine 2021―Apr―27 Angiotensin-(3-4) modulates the overweight- and undernutrition-induced ACE2 downregulation in renal proximal tubule cells: implications for COVID-19? Rafael Luzes, Humberto Muzi-Filho, Amaury Pereira-Acácio, Thuany Crisóstomo, Adalberto Vieyra
60 [GO] Exploration of Neuroprotective Therapy 2021―Apr―20 P2X7 receptor involvement in COVID-19 disease Peter Illes
61 [GO] Exploration of Immunology 2021―Mar―31 In silico investigation of binding affinities between human leukocyte antigen class I molecules and SARS-CoV-2 virus spike and ORF1ab proteins Spyros A. Charonis, Effie-Photini Tsilibary, Apostolos P. Georgopoulos
62 [GO] Exploration of Medicine 2020―Oct―31 High-performance computing will assist experiments in recovery from COVID-19
63 [GO] Exploration of Medicine 2020―Jul―17 Visual communication and learning from COVID-19 to advance preparedness for pandemics José de la Fuente, José Bedia, Christian Gortázar
 [1] 

63 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec